FN1 and Alzheimer disease: Several studies reported higher amounts of high molecular FN forms in plasma, CSF and frontal and temporal cortex of AD patients compared to vascular dementia and controls [37–39], corroborating our results showing higher levels of fibronectin fragments 3 and 4 in AD patients compared to FTD patients and controls.